понедельник, 13 февраля 2017 г.

Biotech firms wary of curbs on skills visas

Biotech firms wary of curbs on skills visas


From tiny startups to global giants, the companies that sustain the $324 billion U.S. biotech industry are increasingly alarmed as President Donald Trump considers following his controversial travel ban with restrictions on skilled foreign immigrants.



from Biotech News